Agerholm-Larsen55 studied the effects of Gaio in 70 overweight and obese subjects in a randomized, double-blind, placebo- and compliance-controlled, parallel protocol.
Agerholm-Larsen55 studied the effects of Gaio in 70 overweight and obese subjectsin a randomized, double-blind, placebo- and compliance-controlled, parallelprotocol.